Update From The God Himself - Dr. Takashi Tsuji
- Thread starter kingjohn
- Start date
- Reaction score
- 984
Because it is all much too Late
- Reaction score
- 1
can I have access to the discords?
- Reaction score
- 1
i need to speak to @pegasus2 urgently
OrganTech CEO Takashi Kondo put update on his LinkedIn profile:
“We raised 4.3M US dollars fund through private placement in 2023.OrganTech restarted our business and R&D.In 2024, we made out licensing contracts and collaboration research contracts with some partners.Our revenue is going to reach over 4.6M in this year.We’re also going to conduct clinical research of hair follicles regeneration therapy and bio integration dental implants.Due to successful business development and research progress, we plan to raise further funding to aim for the next stage.Thanks for kindly support to our all partners.“
Check out Takashi Kondo LinkedIn profile:
www.linkedin.com
“We raised 4.3M US dollars fund through private placement in 2023.OrganTech restarted our business and R&D.In 2024, we made out licensing contracts and collaboration research contracts with some partners.Our revenue is going to reach over 4.6M in this year.We’re also going to conduct clinical research of hair follicles regeneration therapy and bio integration dental implants.Due to successful business development and research progress, we plan to raise further funding to aim for the next stage.Thanks for kindly support to our all partners.“
Check out Takashi Kondo LinkedIn profile:
Takashi Kondo on LinkedIn: We raised 4.3M US dollars fund through private placement in…
We raised 4.3M US dollars fund through private placement in 2023. OrganTech restarted our business and R&D. In 2024, we made out licensing contracts and…
Next Era Biotechnology AWARD
At the WSJ-sponsored "The Future of Everything 2024" Next Era Leaders AWARD ceremony held in New York, our company's Kondo was awarded the "Next Era Biotechnology AWARD" category.
In addition, the award ceremony will be broadcast on Nikkei CNBC's program "New Wave of the Era." A feature article will be published in the national business magazine "Qualitas."
OrganTech’s CEO, Takashi Kondo, on WSJ ceremony.
弊社近藤が「Next Era Biotechnology AWARD」を受賞しました - 株式会社オーガンテック
弊社近藤がニューヨークにて開催されたWSJ主催の式典にて、「Next Era Biotechnology AWARD」を受賞しました。
www.organ-tech.jp
Running up a company cost a LOT OF money, running up a clinical trials cost a LOT OF money, building infrastructure to deliver your product cost a LOT OF money. Nothing is free and nothing is cheap in biopharma industry.
So, promoting company on big events is big plus for getting more investments and collaboration with bigger companies.
So, promoting company on big events is big plus for getting more investments and collaboration with bigger companies.
@pegasus2 yea give us the dc link